On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Immunologik GmbH's own share of each project, not the project's full budget.
- Horizon Europe€147k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- iMPactPartner
Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity
Horizon Europe · 2021–2023 · Project on CORDIS ↗
€147ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Metriopharm AGSwitzerland · 1 shared project
- Catalyze B.V.Netherlands · 1 shared project
- Mc Toxicology Consulting GmbHAustria · 1 shared project
- Blust VolkerAustria · 1 shared project
- Metriopharm Deutschland GmbHGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- coronaviruses
- mortality
- pandemics
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.